Short Description Cognition Therapeutics develops sigma‑2 receptor modulators to support healthy longevity.
Description Cognition Therapeutics is a biotechnology innovator targeting the fundamental mechanisms of aging through sigma‑2 receptor modulators. The company leverages advancements in neurodegeneration and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Cognition Therapeutics aims to extend healthspan and improve quality of life across the globe.
Address 2403 Sidney St, Suite 200, Pittsburgh, PA, USA